drugset / Trial / NCT02113540

Assessment of the Effect of Atorvastatin on Prevention of CIN in Patients Undergoing Coronary Angiography

NCT02113540 ↗

RandomizedParallel-groupTriple-blindPrevention

Summary

As the effect of statin use before the angiography to prevent contrast induced nephropathy (CIN) is not well-known, the aim of the current study is to assess the effect of atorvastatin on prevention of CIN in patients undergoing coronary angiography.

Timeline

Start
2012-01
Primary completion
2014-05
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule — —